180 Life Sciences Corp (ATNF)
1.62
0.00 (0.00%)
USD |
NASDAQ |
May 28, 16:00
1.50
-0.12
(-7.41%)
After-Hours: 20:00
180 Life Sciences Cash from Operations (Quarterly): -1.033M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.033M |
December 31, 2023 | -2.16M |
September 30, 2023 | -1.776M |
June 30, 2023 | -3.117M |
March 31, 2023 | -3.870M |
December 31, 2022 | -2.927M |
September 30, 2022 | -3.596M |
June 30, 2022 | -3.532M |
March 31, 2022 | -2.073M |
Date | Value |
---|---|
December 31, 2021 | -5.028M |
September 30, 2021 | -4.003M |
June 30, 2021 | -4.011M |
March 31, 2021 | -6.33M |
December 31, 2020 | -3.216M |
September 30, 2020 | -0.054M |
June 30, 2020 | -0.1926M |
March 31, 2020 | -0.409M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.33M
Minimum
Mar 2021
-0.054M
Maximum
Sep 2020
-2.784M
Average
-3.117M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
GT Biopharma Inc | -4.163M |
Altimmune Inc | -16.36M |
Seelos Therapeutics Inc | -4.642M |
Oragenics Inc | -3.064M |
MAIA Biotechnology Inc | -3.587M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | -0.2644M |
Free Cash Flow | -8.086M |
Free Cash Flow Per Share (Quarterly) | -1.619 |
Free Cash Flow Yield | -1.07K% |